APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS

Identification of Apo-Desvenlafaxine Extended-Release Tablets

No description

Google image searchProduct monograph

Active ingredient

desvenlafaxine (desvenlafaxine succinate), 100 MG

DIN: 02467127

Dosage form(s): TABLET (EXTENDED-RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: APOTEX INC

Date: 02-NOV-2022

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06A — ANTIDEPRESSANTS (ATC, ATC/DDD)
• N06AX — Other antidepressants (ATC, ATC/DDD)
• N06AX23 — DESVENLAFAXINE (ATC/DDD)

Reference brand drug: Pristiq

External Links for Apo-Desvenlafaxine Extended-Release Tablets

Search on Google

• Apo-Desvenlafaxine Extended-Release Tablets side effects
• Apo-Desvenlafaxine Extended-Release Tablets dosage
• desvenlafaxine side effects
• desvenlafaxine dosage

Apotex Inc

Go to Apotex website to see drug product details. Sometimes you can find apo-desvenlafaxine extended-release tablets photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.